EDITOR’S QUOTE: “Intratumoral G207 (HSV-1 virus) alone and with radiation had an acceptable adverse-event profile with evidence of responses in patients with recurrent or progressive pediatric high-grade glioma. G207 converted immunologically ‘cold’ tumors to ‘hot’.”
